Status:
UNKNOWN
Head-to-head Comparison of Positron Nuclide Radio-labeled FAPI and 18F-FDG PET/CT in Patients With Malignant Tumors
Lead Sponsor:
Guangdong Provincial People's Hospital
Conditions:
Renal Cell Carcinoma
Gastric Cancer
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
The latest research has found that the use of positron-labeled FAP inhibitors for targeting FAP has achieved very good results in displaying tumor stroma, especially for tumors with poor FDG PET/CT ob...
Detailed Description
At the beginning of 2022, the National Cancer Center released the latest statistical data showing that the incidence rate of malignant tumors in China reached 293.91/100000, and the mortality rate rea...
Eligibility Criteria
Inclusion
- Patients with high clinical suspicion of malignant tumors;
- Those who have undergone endoscopic biopsy or puncture biopsy indicating malignant tumors but have not undergone surgery or chemotherapy;
- Previous history of malignant tumor surgery, suspected of recurrence or distant metastasis;
- There is a willingness for puncture biopsy or surgery, and there are no contraindications for puncture biopsy or surgery, and there are no contraindications for anesthesia;
- Sign an informed consent form and undergo a nuclear medicine examination, without any contraindications, with the ability and willingness to participate in the follow-up plan.
Exclusion
- Those who cannot tolerate puncture biopsy or surgical contraindications;
- Those who have undergone radiotherapy and chemotherapy in the past 3 months;
- Individuals who are allergic to multiple drugs or foods;
- Those who refuse nuclear medicine examinations;
- Those who do not agree to sign an informed consent form and are unable or willing to follow up.
Key Trial Info
Start Date :
January 11 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 1 2025
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT06182644
Start Date
January 11 2024
End Date
September 1 2025
Last Update
January 22 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Guangdong Provincial People's Hospital
Guangzhou, Guangdong, China, 510080